Cell & Tissue Preservation Market Anticipated to Grow at Much Faster Rate in Upcoming Years 2021-2031

Cell & Tissue Preservation Market: Introduction
According to the report, the global cell & tissue preservation market was valued at US$ 2.95 Bn in 2020. It is projected to expand at a CAGR of 11.9% from 2021 to 2031. Cell & tissue preservation must be maintained at appropriate temperatures to preserve integrity of the tissue. The receiving facility is responsible for maintaining records; documenting that allograft tissue is maintained at adequate environmental requirements during transportation and stored as per the manufacturer's recommendations for the specific tissue.

Request Sample: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=82712

The current methods of cell & tissue preservation involve freeze-drying, deep-freezing, and cryopreservation. Each of these techniques could be utilized for storage of ligament and meniscal allografts. Deep-freezing is a highly common preservation method for ligament and meniscal allografts, entailing simply freezing the tissue to -80°C. The grafts could be preserved for 3 to 5 years. In the freeze-drying process, moisture is removed from the tissue and the graft is vacuum packaged. It could be stored at room temperature for 3 to 5 years; however, it requires rehydration before implantation. Deep-freezing and freeze-drying allograft tissue reduces immunogenicity by killing antigen-bearing cells. Cryopreservation is a process of controlled-rate freezing with extraction of cellular water by means of glycerol and dimethyl sulfoxide. This process preserves some cells and provides a 10-year shelf life.
Increase in Healthcare Expenditure
The increase in healthcare expenditure is estimated to further allow access to quality healthcare and advanced products that include biopreservation facilities, thereby broadening growth prospects. Additionally, gene banks, hospitals, and biobanks that are significant end users of the market, are encouraging most players to develop technologically advanced biopreservation products to enhance patient outcomes. The presence of government healthcare initiatives that provide funds, grants, and contracts for research has fueled R&D activities deployed by various companies. This, in turn, has boosted the scope for adoption of advanced bio-preservation services, which, in turn, is anticipated to fuel the penetration rate during the forecast period.
Rising R&D investments by companies and research communities to improve their capabilities and render efficient products & services are estimated to further create opportunities. For instance, the establishment of the Cooperative Human Tissue Network (CHTN), which addressed the operational dimension of bio-banking, exemplifies consistent efforts by the research community.

Enquiry Before Buying: https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=82712

Tissues to Lead Cell & Tissue Preservation Market
In terms of type, the global cell & tissue preservation market has been classified into cells & tissues. Cells have been split into mammalian cells and others (microorganisms and plant cells). The tissues segment has been split into blood, bone, soft tissues, skin, and others. The tissues segment accounted for 47.6% share of the market in 2020. The segment is anticipated to expand at a CAGR of 11.7% from 2021 to 2031.
Rising investments in the field of regenerative medicine research is projected to boost the cell & tissue preservation market. The knowledge of human cells and tissues being used for further research and development novel treatment therapies led to the introduction of bio banking. Collection, processing, and storage of the samples and the regarding data are the basic function of biobanks.
Therapeutics to Dominate Cell & Tissue Preservation Market
Based on application, the global cell & tissue preservation market has been categorized into therapeutics, research & development, drug discovery, and others. The therapeutics segment accounted for 40.1% share of the cell & tissue preservation market in 2020. The segment is projected to expand at a CAGR of 11.8% from 2021 to 2031. Clinical/therapeutic applications majorly utilize tissue banking, as it involves different types of grafting such as cord blood, stem cell, and others.

Request Brochure: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=82712

Equipment to be Highly Lucrative Segment
In terms of product, the global cell & tissue preservation market has been divided into equipment, bio preservation media, and software. The equipment segment has been further sub-segmented into freezers, thawing equipment, refrigerators, storage systems, and others. The bio preservation media segment has been further bifurcated into home-brew media and pre-formulated media. The equipment segment was valued at US$ 2,026.1 Mn in 2020 and is projected to reach US$ 6,805.9 Mn in 2031, expanding at a CAGR of 11.8% from 2021 to 2031. This can be attributed to an increase in the demand for biobanks for the past few years and its extensive usage in DNA, plasma, stem cell, and tissue research.
Biobanks to be Key End User
Based on end user, the global cell & tissue preservation market has been divided into biobanks, hospitals & others. The biobanks segment accounted for 68.7% share of the market in 2020. The segment is projected to gain market share marginally to reach 70.5% in 2031. This can be attributed to the growing awareness among researchers about the benefits of stem cells preservation. Furthermore, increasing number of sperm & egg banks and adoption of assisted reproductive technology in animals are key factors estimated to fuel the cell & tissue preservation market growth.
North America to Lead Cell & Tissue Preservation Market
In terms of region, the global cell & tissue preservation market has been divided into North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. North America is projected to be a highly attractive market and exhibit an attractiveness index of 2.0 during the forecast period. The market in the region is anticipated to expand at a higher CAGR from 2021 to 2031, owing to consistent drug developments as well as advent of advanced therapies in the field of biomedical research.

Request for covid19 Impact Analysis: https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=82712

A significant rise in patient base requiring high-end treatment of chronic diseases is also responsible for the high demand for biopreservation products and services across the region. Major pharmaceutical companies are engaged in the commercialization of advanced preservation equipment and their subsequent adoption in the research community.
Competition Landscape
The global cell & tissue preservation market is fragmented due to the presence of a large number of prominent players. Key players operating in the global cell & tissue market include Thermo Fisher Scientific, Inc., Lonza, BD, Merck KGaA, Cytiva, Agilent Technologies, Inc., Avantor, Inc., FUJIFILM Irvine Scientific, BioLifeSolutions Inc., AMSBIO, Princeton CryoTech, STEMCELL Technologies Inc., LGC SeraCare, Corning Incorporated, and CellGenix GmbH.

More Trending Reports by Transparency Market Research:

https://www.prnewswire.com/news-releases/regenerative-medicine-market-to-gain-valuation-of-us-12-9-bn-by-2028--states-tmr-study-301483969.html

https://www.prnewswire.com/news-releases/contraceptives-market-to-gain-valuation-of-us-2-7-bn-by-2028--notes-study-by-tmr-301473001.html

Contact
Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com/

About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.

This release was published on openPR.